Reuters logo
BRIEF-GlaxoSmithkline and Innoviva announces positive impact results for Trelegy in COPD
September 20, 2017 / 6:17 AM / in 2 months

BRIEF-GlaxoSmithkline and Innoviva announces positive impact results for Trelegy in COPD

Sept 20 (Reuters) - GLAXOSMITHKLINE PLC:

* POSITIVE IMPACT RESULTS FOR TRELEGY IN COPD

* CO, INNOVIVA REPORT POSITIVE HEADLINE RESULTS FROM STUDY SHOWING SINGLE INHALER TRIPLE THERAPY TRELEGY ELLIPTA REDUCED COPD EXACERBATIONS

* GLOBAL REGULATORY FILINGS WITH IMPACT STUDY ARE EXPECTED TO COMMENCE IN Q2 OF 2018 Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below